# Epidemiology and Management of Metastatic Breast Cancer

> **NCT01711502** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 128 (actual)

## Conditions studied

- Breast Cancer Nos Metastatic Recurrent

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01711502
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2014-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01711502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01711502, "Epidemiology and Management of Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01711502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*